The Research and Development team at T3 Pharmaceuticals focuses on discovering and developing innovative cancer treatments. This multidisciplinary team, consisting of experts in development, CMC (Chemistry, Manufacturing, and Controls), in vivo pharmacology, bioanalytics, and patent research, collaborates to bring breakthrough therapies from concept to clinical trials. Their collective efforts aim to advance the company's mission to improve the lives of cancer patients.
Alain Mazé
Senior Scientist
Aruna Noah Nathan
Patent Research Analyst
Christian Arquint
CMC project manager / Senior s...
Christoph Schmutz
Senior Scientist /CMC Project ...
Debora Schmitz-Rohme...
Head of Development
Falk Saupe
Head of In Vivo Pharmacology
Mathias S. Dick
Head of Bioanalytics
Mélodie Duval
Senior Scientist
Simon Marlaire
Senior Researcher
Tiphaine Haas
Junior Researcher
View all